- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04538729
Use of Alternative Therapy in Acne Vulgaris Patients
January 2, 2021 updated by: Melek Aslan Kayıran, Istanbul Medeniyet University
Acne Vulgaris is a chronic skin disease.
However, chronic and repetitive due to the quality of life and psychological status of patients can affect.
Today, although the treatment is repetitive, chronic and requires follow-up due to the disease patients can turn to alternative and complementary medicine techniques.
In recent years, studies on alternative medicine and complementary therapies have been noted in the medical literature.
These studies also include Case Reports related to acne vulgaris.
However, in our country, there is no study that tells us whether patients with acne vulgaris apply these treatments or not and what the practitioners think about the success of the treatment.
The aim of the study will be to clarify issues such as whether patients with Acne Vulgaris apply alternative medicine and complementary therapies for their disease.
Study Overview
Study Type
Observational
Enrollment (Actual)
1571
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Istanbul, Turkey
- Melek Aslan Kayıran
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
12 years to 60 years (ADULT, CHILD)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Acne vulgaris Patients between age 12-60
Description
Inclusion Criteria:
- Acne vulgaris Patients between age 12-60
Exclusion Criteria:
- the ones who don't want to answer the questions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
acne vulgaris questionnaire
Time Frame: september 2020
|
Alternative medicine and complementary therapies that acne vulgaris patients apply without informing the doctor, how they learn these techniques, what make them use these techniques for their illness
|
september 2020
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
March 1, 2020
Primary Completion (ACTUAL)
September 1, 2020
Study Completion (ACTUAL)
November 30, 2020
Study Registration Dates
First Submitted
August 31, 2020
First Submitted That Met QC Criteria
September 3, 2020
First Posted (ACTUAL)
September 4, 2020
Study Record Updates
Last Update Posted (ACTUAL)
January 5, 2021
Last Update Submitted That Met QC Criteria
January 2, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IstanbulMU9
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acne Vulgaris
-
Nexgen Dermatologics, Inc.Unknown
-
Galderma R&DCompletedSevere Acne VulgarisUnited States, Canada, Puerto Rico
-
Sebacia, Inc.CompletedInflammatory Acne VulgarisUnited States
-
Rejuva Medical AestheticsHealMD, LLCNot yet recruitingAcne Vulgaris (Disorder)United States
-
InMode MD Ltd.Active, not recruitingInflammatory Acne VulgarisUnited States
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingModerate to Severe Acne VulgarisChina
-
PollogenLumenis Be Ltd.RecruitingModerate to Severe Acne VulgarisUnited States
-
Boston PharmaceuticalsCompletedModerate to Severe Acne VulgarisUnited States, Canada
-
Bispebjerg HospitalCompleted
-
Actavis Mid-Atlantic LLCCompletedMILD TO SEVERE ACNE VULGARISIndia
Clinical Trials on Acne Vulgaris
-
Nantes University HospitalRecruiting
-
Istanbul Medeniyet UniversityUnknown
-
South Valley UniversityNot yet recruitingAcne Vulgaris
-
Chang Gung Memorial HospitalRecruiting
-
BiogenWithdrawn
-
Aalborg UniversityRecruitingSleep Deprivation | Histamine | CowhageDenmark
-
Next Science TMSkin Laser & Surgery SpecialistsTerminatedAcne VulgarisUnited States
-
Dr. Behnood AbbasiCompletedType 2 Diabetes MellitusIran, Islamic Republic of
-
Shahid Beheshti UniversityCompletedBlood Pressure | Cardiovascular Risk Factor | Lipid ProfileIran, Islamic Republic of
-
Johnson & Johnson Consumer Inc. (J&JCI)Completed